Teva Pharma Industries Stock Analysis

Teva Stock Analysis Notes

About 57.0% of the company shares are owned by institutional investors. The book value of Teva Pharma was at this time reported as 5.35. The company has Price/Earnings To Growth (PEG) ratio of 1.29. Teva Pharma Industries recorded a loss per share of 0.85. The entity last dividend was issued on the 27th of November 2017. The firm had 2:1 split on the 1st of July 2004. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States. To find out more about Teva Pharma Industries contact Kare Schultz at 972 3 914 8213 or learn more at https://www.tevapharm.com.

Teva Pharma Industries Investment Alerts

Teva Pharma Industries Upcoming and Recent Events

Teva Largest EPS Surprises

View All Earnings Estimates

Teva Pharma Environmental, Social, and Governance (ESG) Scores

Teva Pharma Thematic Classifications

Teva Stock Institutional Investors

Note, although Teva Pharma's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Teva Market Capitalization

The company currently falls under 'Large-Cap' category with a current market capitalization of 18.77 B.

Teva Profitablity

The company has Profit Margin (PM) of (0.06) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.23 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.23.

Management Efficiency

Teva Pharma Industries has return on total asset (ROA) of 0.0556 % which means that it generated a profit of $0.0556 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1752) %, meaning that it created substantial loss on money invested by shareholders. Teva Pharma's management efficiency ratios could be used to measure how well Teva Pharma manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to -0.03. In addition to that, Return On Capital Employed is expected to decline to 0.01. At present, Teva Pharma's Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Fixed Asset Turnover is expected to grow to 3.42, whereas Total Assets are forecasted to decline to about 26.4 B.

Technical Drivers

As of the 30th of November, Teva Pharma has the Risk Adjusted Performance of (0.05), coefficient of variation of (1,294), and Variance of 3.14. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Teva Pharma Industries, as well as the relationship between them.

Teva Pharma Industries Price Movement Analysis

Teva Pharma Industries Insider Trading Activities

Teva Pharma Outstanding Bonds

Teva Pharma Predictive Daily Indicators

Teva Pharma Corporate Filings

Teva Pharma Forecast Models

Teva Pharma's time-series forecasting models are one of many Teva Pharma's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Teva Pharma's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Teva Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Teva shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Teva Pharma. By using and applying Teva Stock analysis, traders can create a robust methodology for identifying Teva entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Teva analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Teva analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Teva Pharma Industries stock analysis indicators help investors evaluate how Teva Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Teva Pharma shares will generate the highest return on investment. By understating and applying Teva Pharma stock analysis, traders can identify Teva Pharma position entry and exit signals to maximize returns.

When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.